In one study of 180 pediatric cases of T-lymphoblastic leukemia/lymphoma, myeloid antigens were expressed in 16.3% of cases; most commonly CD33, in 13% of cases, followed by CD13 in 7.1% of cases, with smaller percentages of cases expressing CD14 and CD15. This evidence concerns the gene CD33 and lymphoma.